Robert J. Delaversano
Principal Financial Officer · Grace Therapeutics, Inc.
- 2026
- Sep 1, 2026
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Robert J. Delaversano files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Opaleye Management Inc. - $576K in GRCE purchases and sales in the last 12 months
- Prashant Kohli - $214K in GRCE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Robert J. Delaversano?
Robert J. Delaversano is a corporate insider, tracked as Principal Financial Officer of Grace Therapeutics, Inc. (GRCE). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Robert J. Delaversano submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.